Clinical trial
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR)
NCT00406783 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Intermittent Allergic Rhinitis (IAR)
- Lead sponsor
- Organon and Co
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2006
- Completion date
- November 30, 2007
- Enrollment
- 547 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.